We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+15.51%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$232M
AUM Growth
-$6.01M
Cap. Flow
-$25.8M
Cap. Flow %
-11.14%
Top 10 Hldgs %
19.26%
Holding
149
New
41
Increased
26
Reduced
26
Closed
55

Sector Composition

Rank Sector Weight
1 Industrials 18.56%
2 Healthcare 16.74%
3 Consumer Discretionary 16.57%
4 Technology 13.75%
5 Energy 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANN
76
DELISTED
ANN INC
ANN
$1.29M 0.56%
31,105
+2,780
+10% +$99.2K
VSI
77
DELISTED
Vitamin Shoppe Inc.
VSI
$1.25M 0.54%
+26,330
New +$1.21M
STAA icon
78
STAAR Surgical
STAA
$1.22B
$1.25M 0.54%
+66,475
New +$1.07M
RNET
79
DELISTED
RigNet, Inc.
RNET
$1.23M 0.53%
+22,835
New +$1.1M
NTUS
80
DELISTED
Natus Medical Inc
NTUS
$1.23M 0.53%
+47,555
New +$1.2M
ECOM
81
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$1.22M 0.53%
+32,295
New +$1.39M
INVN
82
DELISTED
Invensense Inc
INVN
$1.16M 0.5%
+49,045
New +$1.03M
AUXL
83
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$1.07M 0.46%
+39,330
New +$1.04M
MDRX
84
DELISTED
Veradigm Inc. Common Stock
MDRX
$938K 0.4%
+52,020
New +$900K
EXAS
85
DELISTED
Exact Sciences
EXAS
$910K 0.39%
+64,215
New +$867K
MDSO
86
DELISTED
Medidata Solutions, Inc.
MDSO
$906K 0.39%
16,665
-8,980
-35% -$547K
SALE
87
DELISTED
RetailMeNot, Inc. Series 1
SALE
$846K 0.36%
+26,445
New +$980K
RARE icon
88
Ultragenyx Pharmaceutical
RARE
$2.43B
$714K 0.31%
+14,595
New +$751K
CVLT icon
89
Commault Systems
CVLT
$5B
$683K 0.29%
10,510
+1,030
+11% +$71.3K
FRGI
90
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$660K 0.28%
14,480
-35,185
-71% -$1.66M
MCHX icon
91
Marchex
MCHX
$79.3M
$596K 0.26%
+56,700
New +$599K
LAB icon
92
Standard BioTools
LAB
$352M
$489K 0.21%
+11,085
New +$488K
CRAY
93
DELISTED
Cray, Inc.
CRAY
$476K 0.21%
+12,745
New +$431K
SBNY
94
DELISTED
Signature Bank
SBNY
$416K 0.18%
3,310
ACAD icon
95
Acadia Pharmaceuticals
ACAD
$4.41B
-38,760
Closed -$969K
ALGN icon
96
Align Technology
ALGN
$12.3B
-44,070
Closed -$2.52M
ALGT icon
97
Allegiant Air
ALGT
$2.78B
-27,115
Closed -$2.86M
ALNY icon
98
Alnylam Pharmaceuticals
ALNY
$28.8B
-15,140
Closed -$974K
AMBA icon
99
Ambarella
AMBA
$3.69B
-50,650
Closed -$1.72M
EFOR
100
Everforth Inc
EFOR
$1.26B
-29,935
Closed -$1.04M

Similar funds

Lisanti Capital Growth's Q1 2014 Portfolio in Review

As of Q1 2014, Lisanti Capital Growth held 149 positions worth $232M, down 2.5% from $238M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $25.8M in Q1 2014, closing 55 positions and reducing 26 holdings. Its most notable exit was Encore Capital Group, an estimated $4.41M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Lisanti Capital Growth opened a new position in KNIGHT TRANSPORTATION INC worth $3.76M.

  • Lisanti Capital Growth's largest Q1 2014 buy was KNIGHT TRANSPORTATION INC: 162,560 shares worth $3.76M.
  • Lisanti Capital Growth added most to MATTRESS FIRM HLDG CORP COM STK (DE) in Q1 2014, an estimated $2.35M increase.
  • Lisanti Capital Growth's biggest Q1 2014 reduction was EXAMWORKS GROUP INC COM STK (DE), cutting an estimated $3.46M.
  • Lisanti Capital Growth fully exited Encore Capital Group in Q1 2014, selling an estimated $4.41M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $232M portfolio in Q1 2014.
  • Lisanti Capital Growth opened 41 new positions and closed 55 in Q1 2014.
  • Lisanti Capital Growth's portfolio value fell 2.5% quarter-over-quarter to $232M.

Based on Lisanti Capital Growth's 13F filing for Q1 2014, filed 15 May 2014.